REVENUE REVENUE (Tables)

12 Months Ended

Oct. 31, 2019

Revenue from Contract with Customer [Abstract]

The following table presents the company’s total revenue and segment revenue disaggregated by geographical region:



	Year Ended October 31, 2019
	Life Sciences and Applied Markets		Diagnostics and Genomics		Agilent CrossLab		Total
	(in millions)
Revenue by Region
Americas	$	692	$	505	$	664	$	1,861
Europe	551		368		522		1,441
Asia Pacific	1,059		148		654		1,861
Total	$	2,302	$	1,021	$	1,840	$	5,163

The following table presents the company’s total revenue disaggregated by end markets and by revenue type:



		Year Ended October 31, 2019
	(in millions)
Revenue by End Markets
Pharmaceutical and Biopharmaceutical		$	1,604
Chemical and Energy		1,199
Diagnostics and Clinical		785
Food		486
Academia and Government		474
Environmental and Forensics		615
Total		$	5,163

Revenue by Type
Instrumentation		$	2,150
Non-instrumentation and other		3,013
Total		$	5,163

Contract with Customer, Asset and Liability

The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the year ended October 31, 2019:



	Contract Liabilities
	(in millions)

Ending balance as of October 31, 2018	$	367
Impact of adoption of new revenue recognition guidance	(11		)
Net revenue deferred in the period	303
Revenue recognized that was included in the contract liability balance at the beginning of the period	(287		)
Change in deferrals from customer cash advances, net of revenue recognized	5
Contract liabilities acquired in business combinations	9
Currency translation and other adjustments	—
Ending balance as of October 31, 2019	$	386